These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6317146

  • 1. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
    Tang ZH.
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
    [No Abstract] [Full Text] [Related]

  • 2. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
    Shang M.
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
    [No Abstract] [Full Text] [Related]

  • 3. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
    Tang ZH.
    Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
    [No Abstract] [Full Text] [Related]

  • 4. Nasopharyngeal mucosal changes in EB virus VCA-IgA antibody positive persons.
    Li EJ, Tan BF, Zeng Y, Wang PZ, Zhong JM, Deng H, Zhu CS, Wei JN, Pan WJ.
    Chin Med J (Engl); 1985 Jan; 98(1):25-30. PubMed ID: 2988864
    [No Abstract] [Full Text] [Related]

  • 5. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)].
    Liu YX, Zeng Y, Dong WP, Cao GR.
    Zhonghua Zhong Liu Za Zhi; 1979 Jan; 1(1):8-12. PubMed ID: 233233
    [No Abstract] [Full Text] [Related]

  • 6. [Detection of early NPC from VCA/IgA antibody positive individuals with anticomplement immunoenzymatic method].
    Zeng Y, Shen SJ, Deng H, Ma JL, Zhang Q, Zhu JS, Cheng JR.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):254-5. PubMed ID: 6295651
    [No Abstract] [Full Text] [Related]

  • 7. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P, Klein G, Henle W, Henle G, Forsby N.
    Biomed Pharmacother; 1983 Aug; 37(1):41-4. PubMed ID: 6311307
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
    Friborg J, Jarrett RF, Liu MY, Falk KI, Koch A, Olsen OR, Duncan P, Wohlfarht J, Chen JY, Melbye M.
    J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Dec; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY, Lau YK, Chia KB, Lim CH.
    Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
    [No Abstract] [Full Text] [Related]

  • 11. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
    Lynn T, Tu S, Hirayama T, Kawamura A.
    Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111
    [No Abstract] [Full Text] [Related]

  • 12. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
    Joncas JH, Rioux E, Wastiaux JP, Leyritz M, Robillard L, Menezes J.
    Can Med Assoc J; 1976 Nov 06; 115(9):858-60. PubMed ID: 186168
    [Abstract] [Full Text] [Related]

  • 13. IgA and nasopharyngeal carcinoma.
    Desgranges C, De-The G.
    IARC Sci Publ (1971); 1978 Nov 06; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract] [Full Text] [Related]

  • 14. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
    Liu YX.
    Zhonghua Zhong Liu Za Zhi; 1983 Sep 06; 5(5):337-9. PubMed ID: 6317314
    [No Abstract] [Full Text] [Related]

  • 15. [Relation between the growth pattern and the quantity of plasma cells of nasopharyngeal cancer (NPC) and serum EBV antibody level].
    Li JT.
    Zhonghua Zhong Liu Za Zhi; 1985 Jan 06; 7(1):9-11. PubMed ID: 2983963
    [No Abstract] [Full Text] [Related]

  • 16. Seroepidemiological studies on carcinoma of the nasopharynx.
    Lin TM, Yang CS, Chiou JF, Tu SM, Lin CC, Liu CH, Chen KP, Ito Y, Kawamura A, Hirayama T.
    Cancer Res; 1973 Nov 06; 33(11):2603-8. PubMed ID: 4355974
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.